RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NDT Pharmaceuticals Stock

NDT Pharmaceuticals Stocks 2024

NDT Pharmaceuticals Stocks

961,230

Ticker

NDTP

ISIN

US63948Q1058

In 2024, NDT Pharmaceuticals had 961,230 outstanding stocks, a 176.65% change from the 347,450 stocks in the previous year.

The NDT Pharmaceuticals Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2011961.23
2010347.45
200942.45
200834.35
200742.03
200634.35

NDT Pharmaceuticals shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue NDT Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates NDT Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of NDT Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating NDT Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

NDT Pharmaceuticals Aktienanalyse

What does NDT Pharmaceuticals do?

NDT Pharmaceuticals Inc is an American company that has been operating in the pharmaceutical industry for over 30 years. It was founded in 1989 by Robert Dickey and is headquartered in New Jersey. The company's focus is on the development and production of prescription drugs, as well as the manufacturing of raw materials for the pharmaceutical industry. The history of NDT Pharmaceuticals Inc dates back to its founding in 1989. Robert Dickey, the company's founder, began his career in the pharmaceutical sector in the 1970s and built his success with The Pharmaceutical Research Institute. This company was later acquired by Pfizer, and in 1989 Dickey joined NDT Pharmaceuticals Inc. At that time, the company had no products and employed only a few people. However, through the dedicated work and innovative ability of Robert Dickey and his team, the company quickly grew and became a major player in the American pharmaceutical market. The business model of NDT Pharmaceuticals Inc is focused on developing prescription drugs and successfully placing them in the market. The company relies on close collaboration with doctors and other medical professionals to best understand and meet the needs of patients. At the same time, the company heavily invests in research and development to stay up to date with the latest medical knowledge and be able to bring innovative products to the market. The company is divided into different divisions to concentrate its focus on various product parameters and meet the needs of patients. These divisions include Hoppliedarkton, which offers products for pain relief and inflammation; Sleepoprofen, which develops and produces medications to support healthy sleep; and Revitalix, which offers products to enhance quality of life based on natural ingredients such as vitamins and antioxidants. Throughout its history, NDT Pharmaceuticals Inc has brought a variety of products to the market aimed at improving health. Some of these products include Naprogesic, a medication for pain treatment during menstruation; Vivenza, an over-the-counter medication for treating sleep disorders; and Revitalift, a highly effective anti-aging complex based on natural plant extracts and vitamins. In conclusion, NDT Pharmaceuticals Inc has established an excellent reputation as a reliable provider of prescription drugs and raw materials for the pharmaceutical industry since its founding. The company relies on close collaboration with medical professionals and a high investment in research and development to develop innovative and effective products. With its different divisions and products, the company aims to improve the health and well-being of its patients. NDT Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating NDT Pharmaceuticals's Shares Outstanding

NDT Pharmaceuticals's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in NDT Pharmaceuticals’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding NDT Pharmaceuticals’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in NDT Pharmaceuticals’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about NDT Pharmaceuticals stock

How many stocks are there of NDT Pharmaceuticals?

The current number of stocks of NDT Pharmaceuticals is 961,230 undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of NDT Pharmaceuticals are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of NDT Pharmaceuticals evolved in recent years?

The number of shares of NDT Pharmaceuticals has increased by 176.65% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. NDT Pharmaceuticals as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of NDT Pharmaceuticals?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does NDT Pharmaceuticals pay?

Over the past 12 months, NDT Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NDT Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of NDT Pharmaceuticals?

The current dividend yield of NDT Pharmaceuticals is .

When does NDT Pharmaceuticals pay dividends?

NDT Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NDT Pharmaceuticals?

NDT Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of NDT Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NDT Pharmaceuticals located?

NDT Pharmaceuticals is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von NDT Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NDT Pharmaceuticals from 9/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/21/2024.

When did NDT Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/21/2024.

What was the dividend of NDT Pharmaceuticals in the year 2023?

In the year 2023, NDT Pharmaceuticals distributed 0 USD as dividends.

In which currency does NDT Pharmaceuticals pay out the dividend?

The dividends of NDT Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NDT Pharmaceuticals

Our stock analysis for NDT Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NDT Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.